Adaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest Update

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,120,000 shares, an increase of 14.8% from the March 15th total of 5,330,000 shares. Based on an average daily volume of 952,800 shares, the days-to-cover ratio is […]

Related Keywords

Chad ,Stacyl Taylor ,R Mark Adams ,Harlan Robins ,Adaptive Biotechnologies Co ,Vanguard Group Inc ,Adaptive Biotechnologies Corp ,Morgan Stanley ,Investment Management ,Blackrock Inc ,Securities Exchange Commission ,Nasdaq ,Sumitomo Mitsui Trust Holdings Inc ,Nikko Asset Management Americas Inc ,Credit Suisse Group ,Scotiabank ,Adaptive Biotechnologies ,Get Rating ,Biotechnologies Stock Down ,Suisse Group ,Mark Adams ,Exchange Commission ,Mitsui Trust Holdings ,Nikko Asset Management Americas ,Asset Management Americas ,Chad Robins ,Chris Carlson ,Adaptive Biotechnologies Daily ,Nasdaq Adpt ,Adpt ,Medical ,Stocks ,Options ,Put ,Call ,